Curasight A/S reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was DKK 18.35 million compared to DKK 11.12 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 DKK | -.--% | +1.49% | -42.54% |
Apr. 16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
Apr. 12 | Curasight A/S Announces Board Changes | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.54% | 29.16M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- CURAS Stock
- News Curasight A/S
- Curasight A/S Reports Earnings Results for the Full Year Ended December 31, 2022